-
The FDA has granted market approval for pitava-statin, the seventh HMG-CoA reductase inhibitor, or "statin." It is a high-potency statin similar to rosuvastatin and atorvastatin.
-
Imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation.
-
Vitamin C supplementation prevents increases in endurance capacity and maximum oxygen uptake, because it prevents some cellular adaptations to exercise.
-
Internet-based self-management resulted in improvements in asthma control and lung function with resultant increases in the number of symptom-free days. However, this did not significantly reduce exacerbation rates.
-
The second competitive, reversible dipeptidyl peptidase-4 (DPP-4) inhibitor has been approved by the FDA for the treatment type 2 diabetes mellitus.
-
Most colorectal cancers overexpress cyclo-oxygenase 2 (COX-2). Primary prevention with aspirin (ASA) is associated with reduced risk for colon cancer and colonic adenoma.
-
A non-iodinated derivative of amiodarone has been approved by the FDA for the treatment of atrial fibrillation and atrial flutter.
-
Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings.
-
For patients with colorectal cancer whose tumors overexpressed COX-2, regular aspirin use was associated with a lower risk of death related to colorectal cancer for about 12 years after initial diagnosis.
-
Adherence to appropriate low-risk dietary and other lifestyle factor changes was associated with significant reductions in the incidence of self-reported hypertension and could have the potential to prevent a large proportion of new onset hypertension in women.
